| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Operating Officer
1 company
Kim Hanjoon Alex serves as a Chief Financial Officer at LAB. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $2.1M at current prices.
Historically, Kim Hanjoon Alex's trades have earned a below-average insider score of 33/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -6.6%.
The biggest single holding is LAB (~$2.1M) as Chief Financial Officer. The recent filings there lean toward selling, a net 4,190 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | LAB Standard Biotools Inc. | Chief Financial Officer | Sell | 1,428 | $0.94 | $1,343.75 | -0.2% | +30.2% | +11.8% | |
| May 22, 2025 | LAB Standard Biotools Inc. | Chief Financial Officer | Sell | 1,355 | $1.00 | $1,357.71 | -0.1% | +28.9% | +7.9% | |
| May 21, 2025 | LAB Standard Biotools Inc. | Chief Financial Officer | Sell | 1,407 | $1.03 | $1,449.21 | -0.2% | +22.1% | -0.0% |